+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 70Years
All Genders
ID07898865

Neoadjuvant CAPOX Chemotherapy and Serplulimab Given Before or After Short-Course Radiotherapy in Locally Advanced Rectal Cancer A Multicenter Randomized Phase II Study with Integrated Multi-omics Analysis

Led by Chongqing University Cancer Hospital · Updated on 2026-10-27

100

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the best sequence for combining chemotherapy and immunotherapy with short-course radiotherapy in patients with locally advanced rectal cancer LARC. This phase II trial compares giving CAPOX chemotherapy plus the PD-1 inhibitor serplulimab either before or after radiotherapy to improve complete response rates. The study also aims to find immune biomarkers that predict treatment response and improve understanding of the tumor environment. Participants are assigned to one of two groups one receives short-course radiotherapy followed by CAPOX chemotherapy plus serplulimab, while the other receives CAPOX plus serplulimab first, then radiotherapy. Radiotherapy is delivered as 25 Gy over 5 fractions in one week, and chemotherapy plus serplulimab are given in three 3-week cycles. Treatment sequencing and detailed tumor sample analyses are part of the study to explore how the timing affects outcomes. During the trial, participants will undergo tumor biopsies, blood tests, and clinical assessments at baseline, after neoadjuvant therapy, and at surgery. Researchers will monitor safety, surgical results, survival, recurrence, and quality of life up to three years. The primary measure is the combined rate of pathological and clinical complete response after one year. Advanced techniques like single-cell RNA sequencing will be used to analyze tumor samples and immune changes throughout treatment.

CONDITIONS

Brief Title

NeoCSR-Omics Trial: CAPOX + Serplulimab Before vs. After Short-course RT in LARC

Research Team

Q

Qishuai Guo

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here